Company News


January 20, 2000

Ono Launches 'Onon Dry Syrup' (pranlukast hydrate)
Ono Pharmaceutical Co., Ltd. (President: Toshio Ueno) launches its bronchial asthma remedy 'Onon Dry Syrup' (pranlukast hydrate) on Thursday, January 20, 2000.

'Onon Capsule' is a leukotriene receptor antagonist, which was approved for the first time in the world as a bronchial asthma remedy in 1995. Since its launch, it has been widely used for adult patients with bronchial asthma. Ono has newly developed this drug in a dry syrup form, and carried out its clinical studies for pediatric bronchial asthma. As with 'Onon Capsule', 'Onon Dry Syrup' proved effective in ameliorating asthmatic symptoms and pulmonary functions. 'Onon Dry Syrup' was granted approval on October 1, 1999, and is now launched on January 20, 2000. To ensure safe and proper use of this drug, Ono will keep medical institutions informed of any update.